• Lithium orotate

Lithium orotate pure powder

9,5018,00

The renewed interest is largely due to its alleged ability to achieve higher serum and brain lithium ion (Li+) concentrations than those observed with equivalent doses of lithium carbonate, which was first reported in 1978.

SKU: lithium-orotate-powder

ACTIVE INGREDIENT: lithium orotate

ADDITIONAL INGREDIENTS:

OTHER NAMES: 4-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-2,6-dioxo-, monolithium salt (9CI);Orotic acid,monolithium salt (8CI);4-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-2,6-dioxo-, lithium salt (1:1);

CAS NUMBER: 5266-20-6

ATC CODE:

FORMULA: C5H3LiN2O4

MOLAR MASS: 162.03 g·mol−1

ITEM TYPE: powder

QUANTITY PER PACK: 1 to 2 grams

SERVINGS PER PACK:

SUGGESTED USE:

STORAGE: Store in a cool and dry place. Keep away from direct sunlight and heat.

WARNING: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drugs or over the counter medications.

DISCLAIMER: Always consult with a qualified health physician before taking any new dietary supplement. This product is not intended to diagnose, treat, cure, or prevent any diseases.

A micro spoon is added to Lithium orotate

The product is not intended for human use. For laboratory use only.

Use

Over-the-counter lithium orotate is promoted as a health supplement for use as a low-dose source of lithium; however, very limited clinical evidence exists to support use. Noncontrolled studies have examined the use of low-dose lithium orotate in the treatment of alcoholism, migraines, and depression associated with bipolar disorder.

Dosing

Adequate clinical studies are lacking to support dosage recommendations.

Contraindications

Avoid use in patients with significant renal disease.

Pregnancy/Lactation

Avoid use. Information regarding use of the orotate salt form of lithium in pregnancy and lactation is lacking. Adverse effects have been observed with use of lithium carbonate or citrate. Lithium is excreted in breast milk; adverse events have been reported in breastfeeding infants.

Interactions

None well documented.

Adverse Reactions

Adverse effects have not been reported for low doses; however, at higher doses, adverse effects associated with lithium pharmaceutical preparations (lithium carbonate, lithium citrate) should be expected.

Toxicology

Information is limited. Nephrotoxicity is associated with high doses and long-term consumption of lithium. Short-term use of lithium orotate at low doses may not be associated with these toxicity concerns.